Clinical Trial Update: Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in diabetic patients with critical limb ischemia ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Diabetic Foot

Drugs mentioned

• Allogeneic adipose tissue mesenchymal stem cells (adipose tissue-derived mesenchymal stem cells)

Snippet

Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Conditions: Limb Ischemia, Diabetic Foot | Phase 2 | Status: COMPLETED